Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Clinical studies on the effectiveness of CoolSculpting been shown to reduce about 20-25% of fat cells in the treatment area
As research continues and peptides become more available to patients, ongoing education about these substances is essential
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Because the blend is copper-containing (GHK-Cu) and lacks the KPV calming component, particular caution in the research literature attaches to histamine-reactive or highly sensitive skin
Systemic copper accumulation is unlikely at standard research doses
Incredible service
